← Open Payments lookup

HONG MAK: Open Payments

NPI 1437568383 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$700 in 14 payments from 10 companies in 2025. Trend: 2023 $187 · 2024 $945 · 2025 $700

Food & beverage: $700
CompanyPaymentsAmount
Gilead Sciences, Inc.3$340
AstraZeneca Pharmaceuticals LP1$125
Takeda Pharmaceuticals U.S.A., Inc.2$51
Syndax Pharmaceuticals, Inc.2$33
Eisai Inc.1$31
Janssen Biotech, Inc.1$30
Genmab U.S., Inc.1$28
Novartis Pharmaceuticals Corporation1$22
Deciphera Pharmaceuticals Inc.1$20
SERVIER PHARMACEUTICALS LLC1$19

Products named: IMFINZI, Vemlidy, Livdelzi, NINLARO, REVUFORJ, Lenvima, TECVAYLI, Tivdak.

Industry payments across NY — which companies pay providers there.